1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Short-Acting Bronchodilators
        1.2.3 Corticosteroids
        1.2.4 Methylxanthines
        1.2.5 Long-Acting Bronchodilators
        1.2.6 Phosphodiesterase-4 Inhibitors
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Chronic Obstructive Pulmonary Disorder Market Perspective (2017-2028)
    2.2 Chronic Obstructive Pulmonary Disorder Growth Trends by Region
        2.2.1 Chronic Obstructive Pulmonary Disorder Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Chronic Obstructive Pulmonary Disorder Historic Market Size by Region (2017-2022)
        2.2.3 Chronic Obstructive Pulmonary Disorder Forecasted Market Size by Region (2023-2028)
    2.3 Chronic Obstructive Pulmonary Disorder Market Dynamics
        2.3.1 Chronic Obstructive Pulmonary Disorder Industry Trends
        2.3.2 Chronic Obstructive Pulmonary Disorder Market Drivers
        2.3.3 Chronic Obstructive Pulmonary Disorder Market Challenges
        2.3.4 Chronic Obstructive Pulmonary Disorder Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Chronic Obstructive Pulmonary Disorder Players by Revenue
        3.1.1 Global Top Chronic Obstructive Pulmonary Disorder Players by Revenue (2017-2022)
        3.1.2 Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Players (2017-2022)
    3.2 Global Chronic Obstructive Pulmonary Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Chronic Obstructive Pulmonary Disorder Revenue
    3.4 Global Chronic Obstructive Pulmonary Disorder Market Concentration Ratio
        3.4.1 Global Chronic Obstructive Pulmonary Disorder Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disorder Revenue in 2021
    3.5 Chronic Obstructive Pulmonary Disorder Key Players Head office and Area Served
    3.6 Key Players Chronic Obstructive Pulmonary Disorder Product Solution and Service
    3.7 Date of Enter into Chronic Obstructive Pulmonary Disorder Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Obstructive Pulmonary Disorder Breakdown Data by Type
    4.1 Global Chronic Obstructive Pulmonary Disorder Historic Market Size by Type (2017-2022)
    4.2 Global Chronic Obstructive Pulmonary Disorder Forecasted Market Size by Type (2023-2028)
5 Chronic Obstructive Pulmonary Disorder Breakdown Data by Application
    5.1 Global Chronic Obstructive Pulmonary Disorder Historic Market Size by Application (2017-2022)
    5.2 Global Chronic Obstructive Pulmonary Disorder Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Chronic Obstructive Pulmonary Disorder Market Size (2017-2028)
    6.2 North America Chronic Obstructive Pulmonary Disorder Market Size by Type
        6.2.1 North America Chronic Obstructive Pulmonary Disorder Market Size by Type (2017-2022)
        6.2.2 North America Chronic Obstructive Pulmonary Disorder Market Size by Type (2023-2028)
        6.2.3 North America Chronic Obstructive Pulmonary Disorder Market Share by Type (2017-2028)
    6.3 North America Chronic Obstructive Pulmonary Disorder Market Size by Application
        6.3.1 North America Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022)
        6.3.2 North America Chronic Obstructive Pulmonary Disorder Market Size by Application (2023-2028)
        6.3.3 North America Chronic Obstructive Pulmonary Disorder Market Share by Application (2017-2028)
    6.4 North America Chronic Obstructive Pulmonary Disorder Market Size by Country
        6.4.1 North America Chronic Obstructive Pulmonary Disorder Market Size by Country (2017-2022)
        6.4.2 North America Chronic Obstructive Pulmonary Disorder Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Chronic Obstructive Pulmonary Disorder Market Size (2017-2028)
    7.2 Europe Chronic Obstructive Pulmonary Disorder Market Size by Type
        7.2.1 Europe Chronic Obstructive Pulmonary Disorder Market Size by Type (2017-2022)
        7.2.2 Europe Chronic Obstructive Pulmonary Disorder Market Size by Type (2023-2028)
        7.2.3 Europe Chronic Obstructive Pulmonary Disorder Market Share by Type (2017-2028)
    7.3 Europe Chronic Obstructive Pulmonary Disorder Market Size by Application
        7.3.1 Europe Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022)
        7.3.2 Europe Chronic Obstructive Pulmonary Disorder Market Size by Application (2023-2028)
        7.3.3 Europe Chronic Obstructive Pulmonary Disorder Market Share by Application (2017-2028)
    7.4 Europe Chronic Obstructive Pulmonary Disorder Market Size by Country
        7.4.1 Europe Chronic Obstructive Pulmonary Disorder Market Size by Country (2017-2022)
        7.4.2 Europe Chronic Obstructive Pulmonary Disorder Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size (2017-2028)
    8.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Type
        8.2.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Share by Type (2017-2028)
    8.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Application
        8.3.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Share by Application (2017-2028)
    8.4 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Region
        8.4.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Chronic Obstructive Pulmonary Disorder Market Size (2017-2028)
    9.2 Latin America Chronic Obstructive Pulmonary Disorder Market Size by Type
        9.2.1 Latin America Chronic Obstructive Pulmonary Disorder Market Size by Type (2017-2022)
        9.2.2 Latin America Chronic Obstructive Pulmonary Disorder Market Size by Type (2023-2028)
        9.2.3 Latin America Chronic Obstructive Pulmonary Disorder Market Share by Type (2017-2028)
    9.3 Latin America Chronic Obstructive Pulmonary Disorder Market Size by Application
        9.3.1 Latin America Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022)
        9.3.2 Latin America Chronic Obstructive Pulmonary Disorder Market Size by Application (2023-2028)
        9.3.3 Latin America Chronic Obstructive Pulmonary Disorder Market Share by Application (2017-2028)
    9.4 Latin America Chronic Obstructive Pulmonary Disorder Market Size by Country
        9.4.1 Latin America Chronic Obstructive Pulmonary Disorder Market Size by Country (2017-2022)
        9.4.2 Latin America Chronic Obstructive Pulmonary Disorder Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size (2017-2028)
    10.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Type
        10.2.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Share by Type (2017-2028)
    10.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Application
        10.3.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Share by Application (2017-2028)
    10.4 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Country
        10.4.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 GSK
        11.1.1 GSK Company Details
        11.1.2 GSK Business Overview
        11.1.3 GSK Chronic Obstructive Pulmonary Disorder Introduction
        11.1.4 GSK Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.1.5 GSK Recent Developments
    11.2 Pfizer
        11.2.1 Pfizer Company Details
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Chronic Obstructive Pulmonary Disorder Introduction
        11.2.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.2.5 Pfizer Recent Developments
    11.3 Merck
        11.3.1 Merck Company Details
        11.3.2 Merck Business Overview
        11.3.3 Merck Chronic Obstructive Pulmonary Disorder Introduction
        11.3.4 Merck Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.3.5 Merck Recent Developments
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Chronic Obstructive Pulmonary Disorder Introduction
        11.4.4 Novartis Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.4.5 Novartis Recent Developments
    11.5 AstraZeneca
        11.5.1 AstraZeneca Company Details
        11.5.2 AstraZeneca Business Overview
        11.5.3 AstraZeneca Chronic Obstructive Pulmonary Disorder Introduction
        11.5.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.5.5 AstraZeneca Recent Developments
    11.6 Boehringer Ingelheim
        11.6.1 Boehringer Ingelheim Company Details
        11.6.2 Boehringer Ingelheim Business Overview
        11.6.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Introduction
        11.6.4 Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.6.5 Boehringer Ingelheim Recent Developments
    11.7 Teva Pharmaceuticals
        11.7.1 Teva Pharmaceuticals Company Details
        11.7.2 Teva Pharmaceuticals Business Overview
        11.7.3 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Introduction
        11.7.4 Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.7.5 Teva Pharmaceuticals Recent Developments
    11.8 Ario Pharma
        11.8.1 Ario Pharma Company Details
        11.8.2 Ario Pharma Business Overview
        11.8.3 Ario Pharma Chronic Obstructive Pulmonary Disorder Introduction
        11.8.4 Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.8.5 Ario Pharma Recent Developments
    11.9 Roche
        11.9.1 Roche Company Details
        11.9.2 Roche Business Overview
        11.9.3 Roche Chronic Obstructive Pulmonary Disorder Introduction
        11.9.4 Roche Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.9.5 Roche Recent Developments
    11.10 Ache
        11.10.1 Ache Company Details
        11.10.2 Ache Business Overview
        11.10.3 Ache Chronic Obstructive Pulmonary Disorder Introduction
        11.10.4 Ache Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.10.5 Ache Recent Developments
    11.11 Almirall
        11.11.1 Almirall Company Details
        11.11.2 Almirall Business Overview
        11.11.3 Almirall Chronic Obstructive Pulmonary Disorder Introduction
        11.11.4 Almirall Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.11.5 Almirall Recent Developments
    11.12 Aquinox Pharmaceuticals
        11.12.1 Aquinox Pharmaceuticals Company Details
        11.12.2 Aquinox Pharmaceuticals Business Overview
        11.12.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Introduction
        11.12.4 Aquinox Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.12.5 Aquinox Pharmaceuticals Recent Developments
    11.13 Asmacure
        11.13.1 Asmacure Company Details
        11.13.2 Asmacure Business Overview
        11.13.3 Asmacure Chronic Obstructive Pulmonary Disorder Introduction
        11.13.4 Asmacure Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.13.5 Asmacure Recent Developments
    11.14 Astellas Pharma
        11.14.1 Astellas Pharma Company Details
        11.14.2 Astellas Pharma Business Overview
        11.14.3 Astellas Pharma Chronic Obstructive Pulmonary Disorder Introduction
        11.14.4 Astellas Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
        11.14.5 Astellas Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Short-Acting Bronchodilators
    Table 3. Key Players of Corticosteroids
    Table 4. Key Players of Methylxanthines
    Table 5. Key Players of Long-Acting Bronchodilators
    Table 6. Key Players of Phosphodiesterase-4 Inhibitors
    Table 7. Key Players of Others
    Table 8. Global Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 9. Global Chronic Obstructive Pulmonary Disorder Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Chronic Obstructive Pulmonary Disorder Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Chronic Obstructive Pulmonary Disorder Market Share by Region (2017-2022)
    Table 12. Global Chronic Obstructive Pulmonary Disorder Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Chronic Obstructive Pulmonary Disorder Market Share by Region (2023-2028)
    Table 14. Chronic Obstructive Pulmonary Disorder Market Trends
    Table 15. Chronic Obstructive Pulmonary Disorder Market Drivers
    Table 16. Chronic Obstructive Pulmonary Disorder Market Challenges
    Table 17. Chronic Obstructive Pulmonary Disorder Market Restraints
    Table 18. Global Chronic Obstructive Pulmonary Disorder Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Chronic Obstructive Pulmonary Disorder Revenue Share by Players (2017-2022)
    Table 20. Global Top Chronic Obstructive Pulmonary Disorder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disorder as of 2021)
    Table 21. Ranking of Global Top Chronic Obstructive Pulmonary Disorder Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disorder Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Chronic Obstructive Pulmonary Disorder Product Solution and Service
    Table 25. Date of Enter into Chronic Obstructive Pulmonary Disorder Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Chronic Obstructive Pulmonary Disorder Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Type (2017-2022)
    Table 29. Global Chronic Obstructive Pulmonary Disorder Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Type (2023-2028)
    Table 31. Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Chronic Obstructive Pulmonary Disorder Revenue Share by Application (2017-2022)
    Table 33. Global Chronic Obstructive Pulmonary Disorder Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Chronic Obstructive Pulmonary Disorder Revenue Share by Application (2023-2028)
    Table 35. North America Chronic Obstructive Pulmonary Disorder Market Size by Type (2017-2022) & (US$ Million)
    Table 36. North America Chronic Obstructive Pulmonary Disorder Market Size by Type (2023-2028) & (US$ Million)
    Table 37. North America Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022) & (US$ Million)
    Table 38. North America Chronic Obstructive Pulmonary Disorder Market Size by Application (2023-2028) & (US$ Million)
    Table 39. North America Chronic Obstructive Pulmonary Disorder Market Size by Country (2017-2022) & (US$ Million)
    Table 40. North America Chronic Obstructive Pulmonary Disorder Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Europe Chronic Obstructive Pulmonary Disorder Market Size by Type (2017-2022) & (US$ Million)
    Table 42. Europe Chronic Obstructive Pulmonary Disorder Market Size by Type (2023-2028) & (US$ Million)
    Table 43. Europe Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022) & (US$ Million)
    Table 44. Europe Chronic Obstructive Pulmonary Disorder Market Size by Application (2023-2028) & (US$ Million)
    Table 45. Europe Chronic Obstructive Pulmonary Disorder Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Europe Chronic Obstructive Pulmonary Disorder Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Chronic Obstructive Pulmonary Disorder Market Size by Type (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Chronic Obstructive Pulmonary Disorder Market Size by Type (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Chronic Obstructive Pulmonary Disorder Market Size by Application (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Chronic Obstructive Pulmonary Disorder Market Size by Region (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Chronic Obstructive Pulmonary Disorder Market Size by Region (2023-2028) & (US$ Million)
    Table 53. Latin America Chronic Obstructive Pulmonary Disorder Market Size by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Chronic Obstructive Pulmonary Disorder Market Size by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Chronic Obstructive Pulmonary Disorder Market Size by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Chronic Obstructive Pulmonary Disorder Market Size by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Chronic Obstructive Pulmonary Disorder Market Size by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Chronic Obstructive Pulmonary Disorder Market Size by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Chronic Obstructive Pulmonary Disorder Market Size by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Chronic Obstructive Pulmonary Disorder Market Size by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Chronic Obstructive Pulmonary Disorder Market Size by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Chronic Obstructive Pulmonary Disorder Market Size by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Chronic Obstructive Pulmonary Disorder Market Size by Country (2023-2028) & (US$ Million)
    Table 65. GSK Company Details
    Table 66. GSK Business Overview
    Table 67. GSK Chronic Obstructive Pulmonary Disorder Product
    Table 68. GSK Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 69. GSK Recent Developments
    Table 70. Pfizer Company Details
    Table 71. Pfizer Business Overview
    Table 72. Pfizer Chronic Obstructive Pulmonary Disorder Product
    Table 73. Pfizer Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 74. Pfizer Recent Developments
    Table 75. Merck Company Details
    Table 76. Merck Business Overview
    Table 77. Merck Chronic Obstructive Pulmonary Disorder Product
    Table 78. Merck Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 79. Merck Recent Developments
    Table 80. Novartis Company Details
    Table 81. Novartis Business Overview
    Table 82. Novartis Chronic Obstructive Pulmonary Disorder Product
    Table 83. Novartis Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 84. Novartis Recent Developments
    Table 85. AstraZeneca Company Details
    Table 86. AstraZeneca Business Overview
    Table 87. AstraZeneca Chronic Obstructive Pulmonary Disorder Product
    Table 88. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 89. AstraZeneca Recent Developments
    Table 90. Boehringer Ingelheim Company Details
    Table 91. Boehringer Ingelheim Business Overview
    Table 92. Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Product
    Table 93. Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 94. Boehringer Ingelheim Recent Developments
    Table 95. Teva Pharmaceuticals Company Details
    Table 96. Teva Pharmaceuticals Business Overview
    Table 97. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Product
    Table 98. Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 99. Teva Pharmaceuticals Recent Developments
    Table 100. Ario Pharma Company Details
    Table 101. Ario Pharma Business Overview
    Table 102. Ario Pharma Chronic Obstructive Pulmonary Disorder Product
    Table 103. Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 104. Ario Pharma Recent Developments
    Table 105. Roche Company Details
    Table 106. Roche Business Overview
    Table 107. Roche Chronic Obstructive Pulmonary Disorder Product
    Table 108. Roche Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 109. Roche Recent Developments
    Table 110. Ache Company Details
    Table 111. Ache Business Overview
    Table 112. Ache Chronic Obstructive Pulmonary Disorder Product
    Table 113. Ache Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 114. Ache Recent Developments
    Table 115. Almirall Company Details
    Table 116. Almirall Business Overview
    Table 117. Almirall Chronic Obstructive Pulmonary Disorder Product
    Table 118. Almirall Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 119. Almirall Recent Developments
    Table 120. Aquinox Pharmaceuticals Company Details
    Table 121. Aquinox Pharmaceuticals Business Overview
    Table 122. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Product
    Table 123. Aquinox Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 124. Aquinox Pharmaceuticals Recent Developments
    Table 125. Asmacure Company Details
    Table 126. Asmacure Business Overview
    Table 127. Asmacure Chronic Obstructive Pulmonary Disorder Product
    Table 128. Asmacure Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 129. Asmacure Recent Developments
    Table 130. Astellas Pharma Company Details
    Table 131. Astellas Pharma Business Overview
    Table 132. Astellas Pharma Chronic Obstructive Pulmonary Disorder Product
    Table 133. Astellas Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2017-2022) & (US$ Million)
    Table 134. Astellas Pharma Recent Developments
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chronic Obstructive Pulmonary Disorder Market Share by Type: 2021 VS 2028
    Figure 2. Short-Acting Bronchodilators Features
    Figure 3. Corticosteroids Features
    Figure 4. Methylxanthines Features
    Figure 5. Long-Acting Bronchodilators Features
    Figure 6. Phosphodiesterase-4 Inhibitors Features
    Figure 7. Others Features
    Figure 8. Global Chronic Obstructive Pulmonary Disorder Market Share by Application: 2021 VS 2028
    Figure 9. Hospitals Case Studies
    Figure 10. Clinics Case Studies
    Figure 11. Others Case Studies
    Figure 12. Chronic Obstructive Pulmonary Disorder Report Years Considered
    Figure 13. Global Chronic Obstructive Pulmonary Disorder Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Chronic Obstructive Pulmonary Disorder Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Chronic Obstructive Pulmonary Disorder Market Share by Region: 2021 VS 2028
    Figure 16. Global Chronic Obstructive Pulmonary Disorder Market Share by Players in 2021
    Figure 17. Global Top Chronic Obstructive Pulmonary Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disorder as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disorder Revenue in 2021
    Figure 19. North America Chronic Obstructive Pulmonary Disorder Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Chronic Obstructive Pulmonary Disorder Market Size Market Share by Type (2017-2028)
    Figure 21. North America Chronic Obstructive Pulmonary Disorder Market Size Market Share by Application (2017-2028)
    Figure 22. North America Chronic Obstructive Pulmonary Disorder Market Size Share by Country (2017-2028)
    Figure 23. United States Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Chronic Obstructive Pulmonary Disorder Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Chronic Obstructive Pulmonary Disorder Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Chronic Obstructive Pulmonary Disorder Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Chronic Obstructive Pulmonary Disorder Market Size Share by Country (2017-2028)
    Figure 29. Germany Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Chronic Obstructive Pulmonary Disorder Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Chronic Obstructive Pulmonary Disorder Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Chronic Obstructive Pulmonary Disorder Market Size Share by Region (2017-2028)
    Figure 39. China Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 45. Latin America Chronic Obstructive Pulmonary Disorder Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Chronic Obstructive Pulmonary Disorder Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Chronic Obstructive Pulmonary Disorder Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Chronic Obstructive Pulmonary Disorder Market Size Share by Country (2017-2028)
    Figure 49. Mexico Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Chronic Obstructive Pulmonary Disorder Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Chronic Obstructive Pulmonary Disorder Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Chronic Obstructive Pulmonary Disorder Market Size Share by Country (2017-2028)
    Figure 55. Turkey Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 59. Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 60. Merck Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 61. Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 62. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 63. Boehringer Ingelheim Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 64. Teva Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 65. Ario Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 66. Roche Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 67. Ache Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 68. Almirall Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 69. Aquinox Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 70. Asmacure Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 71. Astellas Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed